Cart
sales@molnova.com
SB 204990
CAS No. 154566-12-8
SB 204990 ( —— )
Catalog No. M23668 CAS No. 154566-12-8
SB 204990 is an effective and specific ATP citrate lyase enzyme inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 84 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 291 | In Stock |
|
| 50MG | 534 | In Stock |
|
| 100MG | 763 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB 204990
-
NoteResearch use only, not for human use.
-
Brief DescriptionSB 204990 is an effective and specific ATP citrate lyase enzyme inhibitor.
-
DescriptionSB 204990 is an effective and specific ATP citrate lyase enzyme inhibitor.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorACLY
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number154566-12-8
-
Formula Weight389.3
-
Molecular FormulaC18H22Cl2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (256.89 mM);H2O:10 mg/mL (25.69 mM; Need ultrasonic)
-
SMILESO[C@](CC(O)=O)(C[C@@H](CCCCCCc(ccc(Cl)c1)c1Cl)O1)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shares BH, et al. Active mitochondria support osteogenic differentiation by stimulating β-catenin acetylation. J Biol Chem. 2018 Oct 12;293(41):16019-16027.
molnova catalog
related products
-
BRITE338733
BRITE 338733 is a novel inhibitor of ATPase. BRITE 338733 inhibits the expression of RecA in bacteria with IC50 value of 4.7 μM for the bacterial infections treatment.
-
Deslanoside
Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
-
ATP synthase inhibit...
ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.
